Recruiting Clinical Trials

Displaying 61 - 70 of 238 result(s)
Study Title Condition Phase Location
Phase I/II Multicenter Study to Assess Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors Neuroblastoma Phase 1, Phase 2
  • Country: 
    Singapore
An Open-label, Multi-center, Phase IV Roll-over Study in Patients With ALK Positive Malignancies Who Have Completed a Novartis-sponsored Ceritinib (LDK378) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Ceritinib ALK Positive Malignancies Phase 4
  • Country: 
    Brazil
  • Country: 
    China
  • Country: 
    France
  • Country: 
Investigator- and Subject-blinded, Randomized, Placebo-controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy Trial of CFZ533 in Pediatric and Young Adult Subjects With New Onset Type 1 Diabetes (T1DM) Type 1 Diabetes Mellitus Phase 2
  • Country: 
    United States
  • Country: 
    Belgium
  • Country: 
    Germany
  • Country: 
A Special Drug Use-results Survey to Evaluate the Safety and Efficacy of Subcutaneous Administration of Cosentyx in Pediatric Patients With Psoriasis Vulgaris, Psoriatic Arthritis, or Pustular Psoriasis Psoriasis Vulgaris, Psoriatic Arthritis, Pustular Psoriasis Not Given
  • Country: 
    Japan
An Open-label, Phase I, Dose Escalation, Expansion Study of MGY825 in Adult Patients With Advanced Non-small Cell Lung Cancer Non-small Cell Lung Cancer Phase 1
  • Country: 
    United States
  • Country: 
    Germany
  • Country: 
    Japan
  • Country: 
A Phase II, Randomized (1:1) Open Label Study to Assess the Efficacy and Safety of Eltrombopag in Combination With Dexamethasone Compared to Dexamethasone, as First-line Treatment in Adult Patients With Newly Diagnosed Immune Thrombocytopenia Immune Thrombocytopenia (ITP) Phase 2
  • Country: 
    Germany
Exploring the Characteristics and Profiles of Relapsing Multiple Sclerosis Patients Initiated on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf Region Relapsing Multiple Sclerosis Not Given
  • Country: 
    United Arab Emirates
A Phase 2, Multi-center, Open-label, Randomized Study of Oral Asciminib Added to Imatinib Versus Continued Imatinib Versus Switch to Nilotinib in Patients With CML-CP Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular ... CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic, Hematologic Diseases Phase 2
  • Country: 
    United States
  • Country: 
    Austria
  • Country: 
    Canada
  • Country: 
International, Non-interventional, Post-Authorization Long-Term Safety Study of Lutathera, in Patients With Unresectable or Metastatic, Well-Differentiated, Somatostatin Receptor Positive, Gastroenteropancreatic Neuroendocrine Tumours Neuroendocrine Tumors Not Given
  • Country: 
    United States
  • Country: 
    France
  • Country: 
    Portugal
  • Country: 
A 5-year, Randomized, Double-blind, Placebo-controlled, Multi-center Study Assessing the Efficacy, Safety, and Tolerability of Intra-articular Regimens of LNA043 Versus Placebo in Patients With Symptomatic Knee Osteoarthritis Osteoarthritis Phase 2
  • Country: 
    United States
  • Country: 
    Japan